In brief — the direct answer
Fetal Cystoscopy is a cutting-edge, minimally invasive surgery used to diagnose and treat Lower Urinary Tract Obstruction (LUTO). Unlike a shunt, which bypasses the blockage, cystoscopy involves passing a microscopic camera (an endoscope) into the baby's bladder to identify the cause of the obstruction directly. If the blockage is caused by **Posterior Urethral Valves (PUV)**—a thin membrane of skin—the surgeon can use a tiny laser or a guide-wire to break the membrane, effectively 'curing' the obstruction and allowing the baby to urinate naturally for the rest of the pregnancy.
What is Fetal Cystoscopy?
The procedure utilizes the world's smallest medical endoscopes, often less than 1mm in diameter.
During the surgery, we navigate into the baby's bladder under ultrasound guidance. Once inside, we can see the internal anatomy in high definition. If we confirm the presence of PUV, we perform a 'Hydro-ablation' or use a laser to clear the airway. This restores the natural pathway of urine, which is physiologically superior to a permanent shunt because it doesn't leave a foreign object in the baby's body.
Who is at risk?
Candidates for cystoscopy are typically male fetuses with signs of 'Keyhole' bladder on ultrasound and who have good prognostic urine markers (dilute urine). The procedure is ideally performed between 18 and 24 weeks of pregnancy. It is more technically demanding than shunting and is only performed at specialized fetal therapy centers like the MFM Unit.
How we diagnose it
The diagnostic phase is critical for choosing the right tool:
- Ultrasound Confirmation: Identifying the characteristic 'Keyhole' sign and checking for renal cysts (which may indicate permanent damage).
- Urine Analysis: Performing a bladder tap to confirm the kidneys are healthy enough to benefit from the surgery.
- Patient Layout: The baby must be in a specific 'bottom-up' position to allow safe entry into the bladder.
What does management involve?
The procedure is performed under local anesthesia and sedation:
- Access: A thin trocar is passed into the baby's bladder.
- Visualization: The 1mm fiber-optic scope is inserted. The surgeon views the bladder neck and the valves on a monitor.
- Intervention: The valves are disrupted using specialized micro-tools. The surgeon confirms the urine flow has been restored before withdrawing the scope.
- Safety: Because the entry site is so small, the risk to the mother is minimal, and the procedure usually takes less than an hour.
What are the outcomes?
Fetal cystoscopy offers several advantages over shunting:
- Definitive Treatment: It targets the cause of the problem, not just the symptom.
- Lower Infection Risk: Since no tube is left behind, the risk of later infection or migration is eliminated.
- Kidney Health: Improving the flow naturally helps the kidneys develop with less 'back-pressure' scarring.
- Success: Survival rates are high (70-80%) when performed on the right candidates.
When to see a subspecialist
Bladder obstructions are time-critical. Every day the bladder remains under pressure, more kidney cells are lost. Referral should occur at the first sign of a 'distended bladder' on a 12 or 20-week scan.
Our lead consultant, Dr. Werner Diehl, specializes in endoscopic fetal surgery. We offer the advanced fiber-optic technology required for cystoscopy, providing a more refined and physiological treatment option for families facing a LUTO diagnosis.
Questions to ask your doctor
References & Clinical Guidelines
- Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO trial)
- Fetal cystoscopy for lower urinary tract obstruction: evaluation and intervention (consensus)
- ISUOG Practice Guidelines: ultrasound assessment of the fetal urinary tract